Furthermore, it is known elevated expression of CCL5 in the cerebral microcirculation of AD patients and that treatment of neurons with CCL5 results in an increase in cell survival and a neuroprotective effect against the toxicity of thrombin and sodium nitroprusside [97]. The gene discussed is CCL5; the disease is Alzheimer disease.